Search results
Namita Thapar Opens Up About Work-Life Balance As Shark: “Taunted As Doing Part Time Job”
Mashable India· 7 days agoEmcure’s Namita Thapar appeared on Karishma Tanna’s latest podcast, ‘Rokda & Dokda’, opening up...
Shark Tank’s Namita Thapar to get Rs 128 crore from Emcure Pharma share sale
Financial Express· 2 days agoNamita Thapar, one of the judges of the famous TV show Shark Tank India will be partially offloading...
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of...
The Economic Times· 3 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals will open for subscription on Wednesday,...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 3 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita ...
Shark Tank India’s Namita Thapar lauds Karishma Tanna for excelling in her career and breaking...
Pinkvilla· 2 days agoDuring a recent appearance on Karishma Tanna’s podcast, Namita Thapar expressed admiration for the...
Shark Tank fame 'Phar-Maa' Namita Thapar to make 293x returns from Emcure IPO
Business Today· 7 days agoNamita Thapar, one of the sharks from Shark Tank India, is all set to offload her stake partially in...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 4 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you need to know
Hindustan Times· 2 days agoEmcure IPO: The price range of the IPO is ₹960-1,008 per share and investors can bid for 14 shares...
Shark Tank India’s Namita Thapar praises Karishma Tanna for breaking stereotypes; says ‘you have...
The Times of India· 2 days agoNamita Thapar of Shark Tank India lauded Karishma Tanna for shattering stereotypes and showcasing...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 2 days agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...